2022 Expert Speakers Stuart Hughes Chief Executive Officer Pathios Therapeutics Wim Dokter Chief Scientific Officer Byondis Stephane Peluso Chief Scientific Officer Infinity Pharmaceuticals Rita Barcia Vice President, Process Development & Operations SIRPant Immunotherapeutics Tatiana Novobrantseva Co-Founder & Chief Scientific Officer Verseau Therapeutics Jessica Haverkamp Associate Director, Macrophage Biology BlueRock Therapeutics Stefan Irion Senior Vice President & Head of Research BlueRock Therapeutics Dalia Burzyn Director, Immuno- Oncology & Inflammation Codiak BioSciences Chen Ankri Head of Clinical & Non-Clinical Pharmacology Enlivex Therapeutics Ltd Juho Jalkanen Chief Operating Officer Faron Pharmaceuticals Lisa Johnson Senior Research Scientist, Biomarker Sciences Gilead Sciences Mark Williams Lecturer in Cell & Molecular Biology Glasgow Caledonian University Stefano Sammicheli Director, Innate Cell Engagers Ichnos Sciences Loui Madakamutil Chief Scientific Officer ImCheck Therapeutics Haley Laken Senior Vice President, Program & Portfolio Strategy Jounce Therapeutics Yaron Pereg Chief Executive Officer KAHR Bio Krzysztof Wicher Vice President, Head of Drug Discovery Macomics Nicolas Poirier Chief Scientific Officer OSE Immunotherapeutics Leonard Reyno Executive Vice President & Chief Medical Officer Pionyr Immunotherapeutics Nadine Jahchan Associate Director, Research Pionyr Immunotherapeutics Ramona Swaby Vice President, Clinical Development Carisma Therapeutics Kipp Weiskopf Whitehead Fellow Whitehead MIT Amit Agarwal Senior Vice President, Clinical Development Arch Oncology Jaume Pons President & Chief Executive Officer ALX Oncology Michael Klichinsky Co-Founder & Chief Scientific Officer Carisma Therapeutics Carol O’Hear Vice President, Clinical Development, Hematology Franchise Head Gilead Sciences Randolf Kerschbaumer Chief Executive Officer OncoOne Debashis Sahoo Associate Professor, Pediatrics, University of California, Founding Director Boolean Lab Meenal Datta Assistant Professor, Aerospace & Mechanical Engineering University of Notre Dame Roy Maute Co-Founder & Chief Scientific Officer Pheast Therapeutics Amira Barkal Co-Founder & Chief Executive Officer Pheast Therapeutics Jamison Grailer Senior Research Scientist Promega VIEW AGENDA